GROSSMAN D KEITH 4

What Happened D. Keith Grossman, a director of Outset Medical, was granted 10,667 restricted stock units (RSUs) on 2026-06-04. The award is reported as an acquisition (transaction code A) with an exercise/acquisition price of $0.00 (i.e., a compensation grant). RSUs have economic value tied to Outset common stock but only convert to shares when they vest.

Key Details

• Transaction date: 2026-06-04; Form 4 filed 2026-06-05 (filed the next day).
• Award: 10,667 RSUs recorded at $0.00 per unit (total reported $0 at grant because this is a grant, not a cash purchase).
• Vesting: Footnote states 100% of the RSUs vest upon the earlier of (i) the one-year anniversary of the grant or (ii) the issuer’s next Annual Meeting of Stockholders.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Transaction code: A = Award/Grant. No indication of tax withholding, 10b5-1 plan, or late filing in the supplied data.

Context RSU grants to directors are typically part of standard compensation and do not necessarily indicate the insider’s personal trading view. RSUs convert into actual shares only when they vest, so this grant increases potential future share ownership rather than immediate market-selling activity.